European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Fresenius Kabi Austria GmbH, Graz, Austria

Watch
Fresenius Kabi Austria GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier is a comprehensive company details as a PDF and publications in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Complete Dossier
Entire company details along with publications bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €/month

Learn more
Learn more
View plans
Risk report
Fresenius Kabi Austria GmbH
Risk Level Evaluation Source
Sanctioned (?)

Name

Fresenius Kabi Austria GmbH
Fresenius Pharma Austria GmbH
Laevosan-GmbH

Identification

Fb
Firmenbuch 078256h
Ccrcom
The Brønnøysund Register Centre 924016256
PT
PT 980316154
Lei
549300J8MBAOIHLRKM41
EUID
ATBRA.078256-000

Address

Hafnerstr. 36, 8055 Graz, Austria
Linz, Austria

Corporate purpose

Chem. pharm. Industry Medical Devices

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
1Chair of the Supervisory Board
2Managing Director
1Deputy Chair of the Supervisory Board
3Member of the Supervisory Board
4Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
tax haven banner
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Real estate
Patents
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2021 to 2024
Profit & Loss
from 2021 to 2024
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Publications

11 Feb 2026
Patent: Packaging system for oxygen-sensitive medicines
3 Feb 2026
Managing Director: Alexander Hohl, Michael Mayr
28 Jan 2026
Managing Director: Michael Mayr · No longer Managing Director: Frank Wilgmann
31 Dec 2025
Patent: Liquid Ephedrine Formulations
6 Nov 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
3 Sept 2025
Wordmark: “LAEVOLAC“
9 Jul 2025
Patent: Pharmaceutical composition for parenteral administration with ibuprofen and a phosphate buffer
7 Jul 2025 in Sat
State Aid (€168,965): FFG Industry Guideline 2024-2026
13 Nov 2024
Patent: Method for the production of oil-in-water emulsions
Year 2024 in Sat
4 State Aids (total €1,825,207): BMK, Promotion of Zero-Emission Commercial Vehicles and Infrastructure [ENIN] …
4 Oct 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
12 Sept 2024
Patent: Liquid bupivacaine formulations
7 Jun 2024
No longer Authorized signatory (ppa) (2)
7 Mar 2024
Authorized signatory (ppa): Michael Sattler
31 Jan 2024
Member of the Supervisory Board: Christian Feldhofer · No longer Member of the Supervisory Board: Stanislav Jerinic
20 Dec 2023
Patent: Compositions with Lactulose to Maintain or Improve Gut Health IN Humans
23 Nov 2023
Authorized signatory (ppa): Daniel Grübler
25 Oct 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
19 Oct 2023
Shareholder: Fresenius Kabi AG · No longer Shareholder: Fresenius HemoCare Beteiligungs GmbH · Capital: €3,500,000
19 Oct 2023
Patent: Liquid Phenylephrine Formulations
8 Sept 2023
Chair of the Supervisory Board: Marc-Alexander Mahl · No longer Chair of the Supervisory Board: Michael Schönhofen
14 Jul 2023
Managing Director: Michael Mayr, Frank Wilgmann · No longer Authorized signatory (ppa) (1)
6 Apr 2023
Patent: Treatment of Clostridioides Difficile Infection
2 Mar 2023
No longer Authorized signatory (ppa) (1)
15 Feb 2023
Authorized signatory (ppa): Dunja Mühlbacher
15 Feb 2023
Authorized signatory (ppa) (1)
20 Dec 2022
No longer Authorized signatory (ppa) (1)
Year 2022 in Epobase
5 European patent filings: System and Method for Monitoring Critical Pharmaceutical Operations …
8 Sept 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
7 Jul 2022
Managing Director: Michael Mayr · No longer Managing Director: Frank-Joachim Simon
14 Apr 2022
Managing Director: Frank-Joachim Simon · No longer Managing Director: Heinz-Peter Riesner
2 Feb 2022
Authorized signatory (ppa): Thomas Kern
18 Nov 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
8 Jul 2021
Authorized signatory (ppa) (1)
6 May 2021
No longer Authorized signatory (ppa) (1)
21 Apr 2021
Patent: Method of Determining the GAS Volume of a PRE-Filled Syringe and USE of the Method for Calibrating a Machine for Filling Syringes
9 Apr 2021
Chair of the Supervisory Board: Michael Schönhofen · Deputy Chair of the Supervisory Board: Marc J. G. Crouton · No longer Chair SB: M. H. · No longer Dep. Chair SB: M. Sch. · No longer SB: M. C
9 Apr 2021 via Fresenius Kabi Pharma Portugal Lda. also 20/12/2013, 28/01/2008
Shareholding: Fresenius Kabi Pharma Portugal Lda
13 Jan 2021
Patent: Syringe packaging system
7 Jan 2021
Utility patent: Piston rod with at least three ring elements for a prefilled syringe
30 Nov 2020
Utility patent: Piston rod with at least three ring elements for a prefilled syringe
25 Nov 2020
Patent: Application Assembly with a Medical Fluid
18 Nov 2020
Patent: Plunger Rod Comprising AT Least Three Annular Elements for a Prefilled Syringe
4 Nov 2020
Utility patent: Piston rod with at least three ring elements for a prefilled syringe
1 Oct 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
1 Oct 2020
No longer Authorized signatory (ppa) (1)
10 Jul 2020
Managing Director: Frank-Joachim Simon · No longer Managing Director: Jens Sauter
21 May 2020
Member of the Supervisory Board: Barbara Gaigg · No longer Member of the Supervisory Board: Ernst Vidovic
11 Mar 2020
Patent: Apparatus and Method for Sorting Containers
14 Feb 2020
Managing Director: Jens Sauter · No longer Managing Director: Andrej Mieth
20 Dec 2019
Patent: Method for Manufacturing OIL-in-Water Emulsions
18 Jul 2019
Managing Director: Andrej Mieth · No longer Managing Director: Oskar Haszonits · No longer Authorized signatory (ppa): Andrej Mieth
12 Jul 2019
Annual report for the year ending 31/12/2018
26 Jun 2019
Patent: Syringe Packaging System and Shell
16 Mar 2019
Member of the Supervisory Board: Ernst Vidovic · No longer Member of the Supervisory Board: Johann Schwarz
30 Jan 2019
Patent: Continuous Process for the Preparation of Crystalline Lactulose
11 Aug 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
22 Jun 2018
Authorized signatory (ppa) (2)
24 Jan 2018
Managing Director: Heinz-Peter Riesner · No longer Managing Director: Christoph W. Funke · No longer Authorized signatory (ppa): Heinz-Peter Riesner
31 Aug 2017
Annual report for the year ending 31/12/2016 (only announcement)
21 Jul 2017
No longer Authorized signatory (ppa) (1)
31 May 2017
Patent: Method for Disinfecting a Process Piping System and Measuring Device for Confirming Clean-in-Place Disinfection
10 Apr 2017
Wordmark: “MILACTEAL“
29 Oct 2016
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
9 Aug 2016
Annual report for the year ending 31/12/2015 (only announcement)
4 May 2016
No longer Authorized signatory (ppa) (1)
2 Mar 2016
Patent: Piston rod with at least three ring elements for a pre-filled syringe
16 Oct 2015
Wordmark: “LAEVOLAC“
16 Oct 2015
Wordmark: “PEPTINA“
6 Oct 2015
Annual report for the year ending 31/12/2014 (only announcement)
10 Sept 2015
Wordmark: “MILACTEAL“
8 Jul 2015
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
5 May 2015
No longer Member of the Supervisory Board (1)
12 Aug 2014
Annual report for the year ending 31/12/2013 (only announcement)
1 Oct 2013
Annual report for the year ending 31/12/2012 (only announcement)
9 Aug 2013
No longer Authorized signatory (ppa) (1)
13 Jun 2013
Authorized signatory (ppa) (1)
12 Apr 2013 via Fresenius SE & Co. KGaA also 19/04/2012
Shareholder: Fresenius SE & Co. KGaA
22 Mar 2013
Managing Director: Christoph W. Funke · No longer Managing Director (1)
21 Feb 2013
Wordmark: “MILACTEAL“
26 Jan 2013
Authorized signatory (ppa) (1)
26 Jan 2013
Chair of the Supervisory Board: Mats Ch. Henriksson · Member of the Supervisory Board: Johann Schwarz · No longer Chair of the Supervisory Board (1) · No longer Member of the Supervisory Board (1)
22 Jan 2013
Wordmark: “MILACTEAL“
29 Aug 2012
Annual report for the year ending 31/12/2011 (only announcement)
17 Jul 2012
Authorized signatory (ppa): Heinz-Peter Riesner
30 May 2012
Member of the Supervisory Board: Stanislav Jerinic · No longer Member of the Supervisory Board (1)
10 Nov 2011
Annual report for the year ending 31/12/2010 (only announcement)
11 May 2011
Wordmark: “PEPTINA“
2 Mar 2011
Wordmark: “PEPTINA“
27 Jan 2011
Authorized signatory (ppa): Andrej Mieth
7 Jan 2011
Wordmark: “PEPTINA“
1 Sept 2010
Annual report for the year ending 31/12/2009 (only announcement)
1 Sept 2010
Member of the Supervisory Board: Carolin Kröner · No longer Member of the Supervisory Board (1)
10 Aug 2010
Wordmark: “LAEVOLAC“
21 Jan 2010
Annual report for the year ending 31/12/2008 (only announcement)
9 Sept 2008
Annual report for the year ending 31/12/2007 (only announcement)
3 Jul 2008
Member of the Supervisory Board (1) · No longer Member of the Supervisory Board (1)
18 Apr 2008
Wordmark: “LAEVILAC“
11 Oct 2007
Annual report for the year ending 31/12/2006 (only announcement)
4 Aug 2007
Authorized signatory (ppa) (1)
10 Jan 2007
Annual report for the year ending 31/12/2005 (only announcement)
18 May 2006
Annual report for the year ending 31/12/2004 (only announcement)
18 May 2006
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
17 Aug 2005
Deputy Chair of the Supervisory Board: Michael Schönhofen · No longer Member of the Supervisory Board: Michael Schönhofen · Member of the Supervisory Board (1) · No longer Dep. Chair SB (1)
16 Apr 2005
No longer Authorized signatory (ppa) (1)
17 Nov 2004
Member of the Supervisory Board (2) · No longer Member of the Supervisory Board (1)
29 Oct 2004
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
30 Sept 2004
Shareholder: Fresenius HemoCare Beteiligungs GmbH, Fresenius Kabi Deutschland GmbH · Capital: €3,500,000
21 Sept 2004
Shareholder: Fresenius HemoCare Beteiligungs GmbH · Merger: Laevosan-Pharma-GmbH · No longer Shareholder: Laevosan-Pharma-GmbH · Capital: €3,500,000
17 Sept 2004
Shareholder: Fresenius Kabi Deutschland GmbH, Laevosan-Pharma-GmbH · Capital: €3,500,000
4 Aug 2004
Annual report for the year ending 31/12/2003 (only announcement)
8 Jan 2004
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
7 Nov 2003
Annual report for the year ending 31/12/2002 (only announcement)
13 Aug 2003
Authorized signatory (ppa) (1) · Merger: Calea Austria Healthcare GmbH
31 May 2003
No longer Authorized signatory (ppa) (1)
19 Oct 2002
Annual report for the year ending 31/12/2001 (only announcement)
19 Oct 2002
No longer Managing Director (1)
31 Jul 2002
Deputy Chair of the Supervisory Board (1) · No longer Deputy Chair of the Supervisory Board (1) · No longer Member of the Supervisory Board (1)
24 Jul 2002
Managing Director: Oskar Haszonits · No longer Authorized signatory (ppa): Oskar Haszonits · No longer Managing Director (1)
17 Nov 2001
Annual report for the year ending 31/12/2000 (only announcement)
10 Nov 2001
Member of the Supervisory Board (2) · No longer Member of the Supervisory Board (2)
3 Aug 2001
No longer Member of the Supervisory Board: Marc J. G. Crouton, Mats Ch. Henriksson · Chair of the Supervisory Board (1) · Dep. Chair SB (1) · No longer Dep. Chair SB (1) · No longer Chair SB (1)
3 Mar 2001
Shareholder: Fresenius Kabi Deutschland GmbH · No longer Shareholder: Fresenius Kabi AG · Capital: 45M ATS
7 Feb 2001
Authorized signatory (ppa): Oskar Haszonits · No longer Authorized signatory (ppa) (1)
2 Dec 2000
Annual report for the year ending 31/12/1999 (only announcement)
11 Oct 2000
No longer Authorized signatory (ppa) (1)
24 Dec 1999
Member of the Supervisory Board (1) · No longer Member of the Supervisory Board (2)
24 Dec 1999
Member of the Supervisory Board: Marc J. G. Crouton · No longer Member of the Supervisory Board (1)
30 Nov 1999
Annual report for the year ending 31/12/1998 (only announcement)
30 Nov 1999
No longer Member of the Supervisory Board (4) · Member of the Supervisory Board (1) · Shareholder: Fresenius Kabi AG · No longer Shareholder: Fresenius AG · Capital: 45M ATS
15 Jul 1999
Member of the Supervisory Board (4) · No longer Member of the Supervisory Board (1)
7 Jul 1999
Member of the Supervisory Board (1) · No longer Member of the Supervisory Board (1)
24 Mar 1999 as Fresenius Pharma Austria GmbH
Annual report for the year ending 31/12/1996 (only announcement)
24 Mar 1999 as Fresenius Pharma Austria GmbH
Authorized signatory (ppa) (1)
24 Mar 1999
Name: Fresenius Kabi Austria GmbH
23 Mar 1999 as Fresenius Pharma Austria GmbH
Annual report for the year ending 31/12/1997 (only announcement)
24 Feb 1998 as Fresenius Pharma Austria GmbH
Member of the Supervisory Board (1)
24 Feb 1998 as Fresenius Pharma Austria GmbH
Authorized signatory (ppa) (1)
27 Jan 1998 as Fresenius Pharma Austria GmbH
No longer Authorized signatory (ppa) (3) · Chair of the Supervisory Board (1) · Member of the Supervisory Board (2) · No longer Managing Director (2) · No longer Chair of the Supervisory Board (1)
25 Oct 1997 as Fresenius Pharma Austria GmbH
Managing Director (1)
4 Oct 1997 as Fresenius Pharma Austria GmbH
Ppa (3) · Dep. Chair SB (1) · MD (2) · SB (1) · No longer Dep. Chair SB (1) · No longer SB (1) · Address · Seat: Graz, Austria · Name: Fresenius Pharma Austria GmbH · Proxy policy
16 Sept 1997 as Laevosan-GmbH
Merger: Frika, Pharmazeutische Fabrik GmbH, Leopold Pharma GmbH
4 Jul 1997 as Laevosan-GmbH
No longer Shareholder (4) · Shareholder: Fresenius AG, Laevosan-Pharma-GmbH · Capital: 45M ATS
2 Jul 1997 as Laevosan-GmbH
Shareholder (3) · No longer Shareholder (1) · Capital: 45M ATS
6 May 1997 as Laevosan-GmbH
Chair of the Supervisory Board (1) · Member of the Supervisory Board (2) · No longer Chair of the Supervisory Board (1) · No longer Member of the Supervisory Board (2)
11 Mar 1997 as Laevosan-GmbH
No longer Shareholder (7) · Shareholder: Fresenius AG · Capital: 45M ATS
14 Feb 1997 as Laevosan-GmbH
No longer Shareholder (9) · Shareholder: Fresenius AG · No longer Shareholder: AGRANA Stärke-GmbH, Raiffeisen Zentralbank Österreich AG · Capital: 45M ATS
10 Oct 1996 as Laevosan-GmbH
Annual report for the year ending 31/12/1995 (only announcement)
9 Oct 1996 as Laevosan-GmbH
Annual report for the year ending 31/12/1994 (only announcement)
8 Oct 1996 as Laevosan-GmbH
Annual report for the year ending 31/12/1993 (only announcement)
5 Oct 1996 as Laevosan-GmbH
Annual report for the year ending 31/12/1992 (only announcement)
19 Jan 1996 as Laevosan-GmbH
No longer Managing Director (1)
16 Jan 1996 as Laevosan-GmbH
Proxy policy
13 Jan 1996 as Laevosan-GmbH
Supplement to the registration dated 15.7.1985 (Entry No. 4 of HRB 770): Resolution of the General Assembly of 9.5.1985 …
10 Oct 1995 as Laevosan-GmbH
Firmenbuch - Vollzug - Republik Österreich vertreten durch das BMJ
2 Feb 1995 as Laevosan-GmbH
Member of the Supervisory Board (1) · No longer Member of the Supervisory Board (1)
19 May 1994 as Laevosan-GmbH
Authorized signatory (ppa) (1)
9 Feb 1994 as Laevosan-GmbH
Reg­is­tra­tion: 09/02/1994 · SH (21) · SB (4) · ppa (4) · Chair SB (1) · Dep. Chair SB (1) · MD (3) · SH: AGRANA Stärke-GmbH, Raiffeisen Zentralbank Österreich AG · Address …
There are no publications matching your search.

Mentions

8 Oct 2025 in Ler
Direct parent
8 Oct 2025 in Ler
Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.